Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Population Genetics Launches Funding Award for Novel Population Sequencing Studies

Published: Monday, October 15, 2012
Last Updated: Monday, October 15, 2012
Bookmark and Share
The Populus Award 2012 offers financial and expert practical support for the completion of a multi-sample gene sequencing project.

Population Genetics Technologies Ltd. has today launched the Populus Award 2012. Inviting abstracts from researchers undertaking a range of population genetics studies, the award will provide the successful applicant with funding and practical support for their sequencing study, as well as access to the extensive expertise and proprietary technologies provided by Population Genetics. These technologies have the power to increase the efficiency and accuracy of next generation sequencing (NGS) studies, allowing researchers to reliably link genotypic variation with phenotype. Other applicants will also have the chance to benefit from the award, receiving collaborative advice and input from the experts at Population Genetics to help them to further advance their research projects.

Dr. Frank Massam, Chief Commercial Officer, Population Genetics, commented: “The Populus Award 2012 provides an ideal opportunity for a research group with limited funds or experience to gain access to the latest technological and practical expertise in the field. Using our proprietary approaches and funding support, we will enable them to accurately sequence either genomic regions of interest or indeed, whole genes in large populations of samples, providing the next leap in sequencing analysis.”

For the successful applicant, Population Genetics will use its established approach to sequence their samples using the NGS platform of their choice. An innovative molecular tagging system enables the accurate sequencing of either multiple non-contiguous or long, contiguous regions from many thousands of samples, in a single experiment. This allows researchers to confidently identify genetic variants attributed to a specific phenotype. Such high quality data is significantly valuable in areas such as human healthcare, as it mediates the rapid discovery of gene variants characteristic of a particular disorder or a specific drug response, facilitating the development of informed, personalised treatment strategies.

Applications must be submitted online by the 30th of November 2012. The successful applicant will be announced in January 2013.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Population Genetics Collaborates with Cambridge University to Unravel the Genetic Causes of Asperger Syndrome
Joint study aims to identify sequence variants in two genes, both of which have been previously associated with Asperger Syndrome.
Monday, July 09, 2012
Dr Alan Schafer to head Population Genetics as CEO
Schafer brings deep experience in research, “big pharma” management and building new businesses.
Thursday, May 03, 2012
Scientific News
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
Using Gene-editing Technology for Faster, Cheaper Antiviral Drug Development
UCLA scientists are working to develop special screening libraries based on a gene-editing technology called CRISPR.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!